Published in Cancer on September 15, 1992
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist (2010) 1.26
Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br J Cancer (1994) 1.19
Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia (2005) 1.13
Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer (1994) 1.08
Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J Cancer (1999) 1.03
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. Br J Cancer (1997) 0.98
Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer (1996) 0.87
Stromal tenascin distribution as a prognostic marker in colorectal cancer. Br J Cancer (1997) 0.84
Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas. Clin Exp Metastasis (2002) 0.80
Colon cancer: survival after curative surgery. Langenbecks Arch Surg (2004) 0.75
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 7.81
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 5.69
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39
Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet (2001) 4.09
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci U S A (1994) 3.42
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22
Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc (2001) 3.18
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol (2000) 2.98
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48
Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity. Lancet (1989) 2.47
Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med (2001) 2.41
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol (1998) 2.31
Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology (2000) 2.25
Studies on repression of the histidine operon. II. The role of the first enzyme in control of the histidine system. Proc Natl Acad Sci U S A (1969) 2.23
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Potential influence of migration bias in birth cohort studies. Mayo Clin Proc (1998) 2.19
Repression of the histidine operon: effect of the first enzyme on the kinetics of repression. J Bacteriol (1969) 2.18
Health effects of acid aerosols on North American children: respiratory symptoms. Environ Health Perspect (1996) 2.17
Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant (1994) 2.16
Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum Hered (2001) 2.14
The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet (1997) 2.14
Teaching and assessing ethics and law in the dental curriculum. Br Dent J (1999) 2.09
Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int (2000) 2.06
Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res (1998) 1.99
Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96
A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg (1994) 1.92
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst (1990) 1.92
Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum Mol Genet (1994) 1.90
Policy implications for implementing evidence-based practices. Psychiatr Serv (2001) 1.87
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol (1998) 1.86
Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet (1994) 1.83
Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine (2001) 1.77
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet (1993) 1.71
Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet (2000) 1.69
Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg (1995) 1.68
High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet (1994) 1.68
Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. Am J Hum Genet (1993) 1.66
Validation of a telephone questionnaire for Parkinson's disease. J Clin Epidemiol (1998) 1.65
Interaction between histidyl transfer ribonucleic acid and the first enzyme for histidine biosynthesis of Salmonella typhimurium. J Bacteriol (1970) 1.64
Cancer in Indigenous Australians: a review. Cancer Causes Control (2003) 1.64
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63
Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet (1998) 1.63
Erythroid cell development in fetal mice: ultrastructural characteristics and hemoglobin synthesis. J Mol Biol (1967) 1.57
Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust (2001) 1.56
Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res (1968) 1.55
Regulation of histidine biosynthesis in Salmonella typhimurium. Curr Top Cell Regul (1972) 1.55
Consequences of neural asynchrony: a case of auditory neuropathy. J Assoc Res Otolaryngol (2000) 1.55
The MHSIP mental health report card. A consumer-oriented approach to monitoring the quality of mental health plans. Mental Health Statistics Improvement Program. Eval Rev (1997) 1.51
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia (1990) 1.49
A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression. Oncogene (2011) 1.49
Biliopleural fistula as a complication of percutaneous biliary drainage: experimental evidence for pleural inflammation. Am Rev Respir Dis (1988) 1.48
Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (1997) 1.46
Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci U S A (1996) 1.45
Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology (2000) 1.45
Hereditary motor and sensory neuropathy type 2C is genetically distinct from types 2B and 2D. Arch Neurol (2000) 1.45
Genotype prediction in the fragile X syndrome. J Med Genet (1991) 1.45
Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin. Nephrol Dial Transplant (1996) 1.44
Increased use of pre-operative imaging and laparoscopy has no impact on clinical outcomes in patients undergoing appendicectomy. Ann R Coll Surg Engl (2011) 1.44
Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy (1997) 1.44
High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients. Nephrol Dial Transplant (1989) 1.43
Hand-held portable sonography for the on-mountain exclusion of a pneumothorax. Wilderness Environ Med (2001) 1.43
Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma. Clin Chem (1997) 1.42
Validity of family history data on PD: evidence for a family information bias. Neurology (2003) 1.41
Interaction between the first enzyme for histidine biosynthesis and histidyl transfer ribonucleic acid. J Bacteriol (1971) 1.41
Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA (2000) 1.40
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Searching for clues to effective use of biologic response modifiers. J Natl Cancer Inst (1991) 1.39
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. Br J Cancer (2010) 1.39
Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc (1994) 1.39
How important is vitamin D deficiency in uraemia? Nephrol Dial Transplant (1997) 1.39
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39
Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome. Am J Hum Genet (1991) 1.38
Treatment of erythropoietin resistance with cyclosporin. Lancet (1994) 1.38
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting. Intern Med J (2009) 1.38
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37